Xeris Biopharma Holdings, Inc. (XERS) Financial Ratios Annual - Discounting Cash Flows
XERS
Xeris Biopharma Holdings, Inc.
XERS (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
Price Ratios
Price to Earnings Ratio -79.81 -9.07 -5.2 -1.91 -1.89 -2.3 -1.47 -3.41 -1.54 -2.82
Price to Sales Ratio 4.38 2.45 1.97 1.64 4.67 10.27 67.63 83.08 26.36 34.65
Price to Book Ratio -1,450 -16.8 -47.71 3.99 2.43 6.21 12.75 2.72 -0.709 -1.17
Price to Free Cash Flow Ratio 58.82 -13.15 -6.56 -1.74 -2.24 -2.17 -2.27 -3.54 -1.62 -2.31
Price to Operating Cash Flow Ratio 118.2 -13.45 -6.88 -1.75 -2.25 -2.2 -2.29 -3.64 -1.66 -2.32
Price Earnings to Growth Ratio -1.46 0.51 0.146 0.035 0.068 0.06 0.049 0.055 -0.019 0
EV to EBITDA 1,370 -33.18 -15.57 -3.7 -1.92 -1.99 -1.38 -2.1
Liquidity Ratios
Current Ratio 1.93 1.67 1.64 2.54 1.8 5.4 3.2 11.59 9.06 13.13
Quick Ratio 1.35 1.19 1.23 2.2 1.57 5.1 3.12 11.59 9.06 13.13
Cash Ratio 0.788 0.713 0.709 1.66 0.851 1.33 0.714 4.49 8.65 12.77
Debt Ratio 0.103 0.84 0.71 0.575 0.289 0.547 0.535 0.266 0 0
Debt to Equity Ratio -44.35 -9.17 -33.79 4.38 0.925 2.58 4.04 0.423 0 0
Long Term Debt to Capitalization 1.03 1.16 1.04 0.805 0.48 0.72 0.802 0.297 0 0
Total Debt to Capitalization 1.02 1.12 1.03 0.814 0.48 0.72 0.802 0.297 0 0
Interest Coverage Ratio 0.331 -1.01 -1.65 -5.81 -16.04 -11.35 -17.09 -23.32 -13,314 -6,616
Cash Flow to Debt Ratio 0.276 -0.136 -0.205 -0.52 -1.17 -1.1 -1.38 -1.76 0 0
Margins
Gross Profit Margin 83.54% 81.86% 82.52% 79.47% 73.14% 54.35% 41.11% 98.3% 99.74% 99.26%
Operating Profit Margin 3.68% -16.57% -26.85% -74.32% -232.2% -408.8% -4,496% -2,407% -1,711% -1,231%
Pretax Profit Margin -5.88% -28.12% -38.74% -87.15% -247.5% -446.5% -4,630% -2,437% -1,707% -1,229%
Net Profit Margin -5.88% -27% -37.98% -85.86% -247.5% -446% -4,614% -2,437% -1,707% -1,229%
Operating Cash Flow Margin 3.97% -18.21% -28.69% -93.33% -207.5% -467.5% -2,960% -2,283% -1,585% -1,496%
Free Cash Flow Margin 7.45% -18.64% -30.07% -93.8% -208.5% -472.8% -2,973% -2,344% -1,630% -1,500%
Return
Return on Assets -4.22% -16.97% -19.3% -27.48% -40.32% -57.27% -115.2% -50.05% -59.01% -39.39%
Return on Equity 73.68% 185.2% 917.9% -209.5% -128.9% -270% -869.9% -79.68% 45.92% 41.36%
Return on Capital Employed 3.86% -15.11% -19.35% -30.25% -51.11% -63.8% -149.9% -54.02% -66.34% -42.67%
Return on Invested Capital 6.04% -21.4% -26.97% -54.2% -72.86% -89.39% -196.3% -92.52% 1,396% 1,047%
Turnover Ratios
Receivables Turnover Ratio 4.95 5.02 4.18 3.58 2.84 2.97 0.58 0.859 1.3 10.64
Payables Turnover Ratio 6.71 16.08 2.48 4.91 1.49 2.99 0.286 0.048 0.002 0.006
Inventory Turnover Ratio 0.649 0.765 0.738 0.915 0.735 1.12 0.737 0 0 0
Fixed Asset Turnover Ratio 9.78 7.2 5.62 11.6 7.48 3.05 0.347 1.21 1.97 3.45
Asset Turnover Ratio 0.719 0.629 0.508 0.32 0.163 0.128 0.025 0.021 0.035 0.032
Per Share Items ()
Revenue Per Share 1.5 1.38 1.19 0.813 0.628 0.479 0.104 0.205 0.767 0.583
Operating Cash Flow Per Share 0.059 -0.252 -0.342 -0.759 -1.3 -2.24 -3.09 -4.67 -12.16 -8.73
Free Cash Flow Per Share 0.112 -0.258 -0.358 -0.762 -1.31 -2.27 -3.1 -4.8 -12.51 -8.75
Cash & Short Term Investments 0.516 0.488 0.526 0.899 1.3 3.14 2.89 9.35 20.73 17.51
Earnings Per Share -0.088 -0.374 -0.452 -0.698 -1.55 -2.14 -4.81 -4.99 -13.09 -7.17
EBITDA Per Share 0.126 -0.143 -0.224 -0.511 -1.43 -1.92 -4.65 -4.9 -13.04 -7.12
Dividend Per Share 0 0 0 0 0 0 0 0 0 0
Enterprise Value Per Share 173 4.75 3.49 1.89 2.75 3.82 6.39 10.3 0 0
Book Value Per Share -0.12 -0.202 -0.049 0.333 1.21 0.792 0.553 6.26 -28.51 -17.33
Price Per Share 173.3 3.39 2.35 1.33 2.93 4.92 7.05 17 20.22 20.22
Effective Tax Rate 0% 3.97% 1.97% 1.48% 0% 0.121% 0.363% 0% -0.004% 0.023%
Short Term Coverage Ratio 1.7 -2.45 0 0 0 0 0 0 0 0
Capital Expenditure Coverage Ratio 18.11 -42.6 -20.78 -196.4 -196.4 -88.05 -213.7 -37.27 -35.23 -459.6
EBIT Per Revenue 0.037 -0.166 -0.268 -0.743 -2.32 -4.09 -44.96 -24.07 -17.11 -12.31
EBITDA Per Revenue 0.084 -0.104 -0.188 -0.628 -2.28 -4.02 -44.56 -23.94 -17 -12.2
Days of Sales Outstanding 73.72 72.64 87.28 102.1 128.5 122.8 629.3 424.8 281.3 34.29
Days of Inventory Outstanding 562 477.4 494.9 398.9 496.6 326.8 495.5 0 0 0
Days of Payables Outstanding 54.38 22.69 147.4 74.28 244.6 122 1,276 7,526 180,310 59,997
Cash Conversion Cycle 581.4 527.4 434.8 426.7 380.5 327.7 -151 -7,101 -180,029 -59,963
Cash Conversion Ratio -0.675 0.674 0.755 1.09 0.838 1.05 0.641 0.937 0.929 1.22
Free Cash Flow to Earnings -1.27 0.69 0.792 1.09 0.843 1.06 0.644 0.962 0.955 1.22
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program